CH Boehringer Sohn AG & Ko. KG - Company Profile Report | Alfabank-Adres
  • Flag United States US
  • Flag Australia AU
  • Flag Canada CA
  • Flag EUR EUR
  • Flag China CN
  • Flag Germany DE
  • Flag New Zealand NZ
  • Flag United Kingdom UK
  • Flag Ireland IE
  • Flag Mexico MX
  • Flag United Nations Global
  • All
mobile menu
business
COMPANY BENCHMARKING • UNITED STATES

CH Boehringer Sohn AG & Ko. KG - Company Profile

Access all 5,000+ company profiles through the Benchmarking Pro Membership. Unlock interactive competitor comparison tools that show you how CH Boehringer Sohn AG & Ko. KG stacks up to the competition and put relevant competitor and industry information at your fingertips.


CH Boehringer Sohn AG & Ko. KG - Overview

Brands
Boehringer Ingelheim, Merial Limited
Description
CH Boehringer Sohn is a private company with an estimated 53,000 employees. In the US, the company has a notable market share in at least two industries: Brand Name Pharmaceutical Manufacturing, Animal Health Biotechnology and Brand Name Pharmaceutical Manufacturing. Their largest market share is in the Animal Health Biotechnology industry, where they account for an estimated 8.2% of total industry revenue and are considered a Rising Star because they display lower market share, but displaying stronger profit and revenue growth than some of their peers.
Company Details

Registered Name: CH Boehringer Sohn AG & Ko. KG

Company Type: Other

Website: https://www.boehringer-ingelheim.com/

Employees: 53000

CH Boehringer Sohn AG & Ko. KG - Operating Industries and Main Competitors

error_outline To view all of CH Boehringer Sohn AG & Ko. KG's operating industries and competitors, see purchase options.

CH Boehringer Sohn AG & Ko. KG - Products and Services

  • Animal Health Biotechnology

    • Of the 4 core revenue-generating products and services in the Animal Health Biotechnology industry, CH Boehringer Sohn AG & Ko. KG offers:
    • Anti-infectives
    • Drugs and vaccines
    • Other

  • Brand Name Pharmaceutical Manufacturing

    • Of the 8 core revenue-generating products and services in the Brand Name Pharmaceutical Manufacturing industry, CH Boehringer Sohn AG & Ko. KG offers:
    • Autoimmune prescriptions
    • Cardiovascular prescriptions
    • Diabetes prescriptions
    • Other prescriptions
    • AAAAAAA - AAAAAAAA Market Share: x.x%
error_outline To view CH Boehringer Sohn AG & Ko. KG's full products and services, see purchase options.

CH Boehringer Sohn AG & Ko. KG - SWOT Analysis

Strengths and weaknesses take into account internal factors, and are based on CH Boehringer Sohn AG & Ko. KG's performance in comparison to its competitors. Opportunities and Threats focus on external influences, and are based on trends and demand in the Animal Health Biotechnology, and Brand Name Pharmaceutical Manufacturing industries.
Strengths
Days Receivables: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Annual Turnover: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Weaknesses
Credit Risk: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Revenue per Employee: $xx
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Opportunities
  • AAAAA
  • AAAAA
  • AAAAA
Threats
  • AAAAA
  • AAAAA
  • AAAAA

error_outline To view CH Boehringer Sohn AG & Ko. KG's full SWOT analysis, see purchase options.

CH Boehringer Sohn AG & Ko. KG - Financial Statements & Ratios

pie_chartCH Boehringer Sohn AG & Ko. KG Income Statement

BALANCE DATE12/31/2022
Revenue24,000.0
Cost of Revenue0000
Cost of Revenue, Non-Cash0000
Gross Profit0000
Other0000

pie_chartCH Boehringer Sohn AG & Ko. KG Balance Sheet

BALANCE DATE12/31/2022
Cash and EquivalentsN/A
Short-Term Investments0000
Derivative Assets, Current0000
Restricted Cash and Investments0000
Other0000

pie_chartCH Boehringer Sohn AG & Ko. KG Cash Flow

BALANCE DATE12/31/2022
Net IncomeN/A
Income (Loss) From Discontinued Operations0000
Depreciation, Depletion and Amortization0000
Amortization of Financing Costs and Discounts0000
Other0000

error_outline To view all financial data for CH Boehringer Sohn AG & Ko. KG, see purchase options.

GET INSTANT ACCESS WITH BENCHMARKING PRO MEMBERSHIP

100% Money Back Guarantee Digicert Trusted

BENCHMARKING PRO

What's Inside
Benchmarking Pro?

A suite of company and industry data that:

Benchmarks companies against industry averages or like-sized segments, as well as close competitors
Identifies real-world strengths, opportunites, weaknesses and threats
Reveals growth opportunities or red flags in a business growth strategy
LEARN MORE

Included in Report

  • Enterprise History & Synopsis
    Enterprise History & Synopsis
  • Enterprise Financial Statements
    Company Financial Statements
  • Financial Ratios
    Industry Market Share Breakdown
  • Industry Averages
    Industry Competitor Matrix
  • Competitive Landscape
    SWOT Analysis
  • Key Enterprise Personnel
    Products and Services
  • Subsidiaries & Ownership Structure
    Key Company Benchmarks

Why purchase access to Benchmarking Pro?

This profile on CH Boehringer Sohn AG & Ko. KG includes:

  • Company Overview
  • Company Revenue and Employee Data
  • Company Financial Statements
  • Industry Market Share Breakdown
  • Industry Competitor Matrix
  • SWOT Analysis
  • Products and Services
  • Key Company Benchmarks
  • Interconnected Competitor Profiles and Industry Reports
  • Full Access to Benchmarking Pro

The Alfabank-Adres Benchmarking Pro solution enables you to:

  • Understand an enterprise’s competitive landscape and how they perform within a like-sized industry segment.
  • Benchmark companies against industry averages, segment averages and their competitors.
  • Identify real-world strengths, opportunities, weaknesses and threats for companies.
  • Target growth opportunities or spot red flags in a business growth strategy.
  • Toggle between company profiles and industry reports for a 360 degree view of a company's position.

Alfabank-Adres provides profiles on thousands of leading companies around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends across all sectors of the economy. This company profile, along with the corresponding competitor and industry data provided, includes thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

Trusted by More Than 10,000 Clients Around the World

  • Alfabank-Adres client - VISA
  • Alfabank-Adres client - ADP
  • Alfabank-Adres client - Deloitte
  • Alfabank-Adres client - AMEX
  • Alfabank-Adres client - Bank of Montreal